Prognosis
U.S. Case Rise Slows; Gilead Sets Remdesivir Use: Virus Update
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
U.S. cases increased 2.3% in the past 24 hours, below the one-week daily average. Gilead Sciences Inc. plans to get its drug remdesivir to patients within days after getting U.S. backing for emergency use.